Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Last Updated
In the Matter of DaVita Inc.
FTC Matter/File Number
1110103
Docket Number
C-4334
Enforcement Type
Part 2 Consents

Case Summary

The Commission required dialysis services company DaVita, Inc. to sell 29 outpatient dialysis clinics around the United States, under a settlement that resolves FTC charges that DaVita’s proposed $689 million acquisition of rival CDSI I Holding Company, Inc., also known as DSI, would be anticompetitive. The settlement preserves competition in 22 geographic markets where the FTC alleges that consumers would be harmed by DaVita’s acquisition of DSI. The settlement requires DaVita to sell the clinics to Dialysis Newco, Inc., a corporation formed by venture capital firms Frazier Healthcare and New Enterprise Associates.